Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

2.

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

Can certain food cravings predict a cancer diagnosis up to three months before other symptoms appear?

5.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot